Equities.com

Followers (7)

Following

The Life Sciences Report $the-life-science-report

The Life Sciences Report: Featuring investment ideas in biotechnology, pharmaceuticals, medical devices, tools and diagnostics in interviews with industry-sector experts–analysts, money managers and newsletter writers–backed by the latest research summaries, news and company profiles. It's a combination of information and insight investors can't get anywhere else.

Articles (137)

Article's title	Publish date
Cancer Vaccine Developer Expands Its Collaboration with Merck	Sep 19, 2018
Coverage Initiated on 'Emerging Antibiotics Growth Story with Multiple Levers for Upside'	Sep 19, 2018
Medical Use of Nitric Oxide Expands as Costs Come Down	Sep 19, 2018
U.S. Biotech Partner Obtains Marketing Authorization for ADHD Treatment in Taiwan	Sep 18, 2018
Why Tiny ITUS's CAR-T Therapy Could Be a Big Deal in Cancer Treatment	Sep 14, 2018
Canadian Biopharma to Outlicense Pain Drug to South Korean Firm	Sep 12, 2018
Biopharma's Positive FDA Meeting Outlines Path Forward for Trial	Sep 11, 2018
Final Approval of Biopharma's Lead Candidate Both Likely and Imminent	Sep 5, 2018
Coverage Initiated on Firm with Paradigm-Shifting Colonoscopy Device	Sep 5, 2018
Oncology-Focused Biotech Receives Orphan Status for AML Drug	Aug 31, 2018

Page 1 of 14

There are no recent news available for The Life Sciences Report.

Watchlist Profile

Symbol	Last Price	Change	% Change
AAPL
loading...
AMZN
loading...
HD
loading...
JPM
loading...
IBM
loading...

The Life Sciences Report $the-life-science-report

Show More

Watchlist Profile

Today's Must Reads

Jeff Kagan: Will 5G and Smartphone Price Increases Stick?

The August Stock market Breakdown Prediction and Analysis

US Stocks Tumble as US-China Trade War Rattles Investors

4 Important Things that Happened in the Cannabis Sector This Week

Throw Everything You Know Out the Window

Gary Bizzo: My Top 11 Disruptive Tech Trends

Modern Monetary Theory Could Destroy This Nation

Big Tech’s Slow Migration From Silicon Valley

When a 16-Year-Old Earns $3 Million, It May Not Be a “Silly Fad”

Gold Stocks and ETFs Continue to Look Attractive

Featured Stock in August’s Exec Comp & ROIC Model Portfolio

Global Stocks higher Ahead of Fed Chairman’s Speech